Orally based diagnosis of celiac Disease: Current Perspectives

Journal of Dental Research

Volumn 87, Issue 12, 2008, Pages 1100-1107

  Pastore, L ^a   Campisi, G ^b   Compilato, D ^b   Muzio, L Lo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Celiac disease; Diagnosis; Oral mucosa; Saliva; Screening

Indexed keywords

ANTIBODY; GLUTEN; SECRETORY IMMUNOGLOBULIN;

CELIAC DISEASE; HUMAN; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; MOUTH MUCOSA; REVIEW; SALIVA;

ANTIBODIES; CELIAC DISEASE; GLUTENS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MASS SCREENING; MOUTH MUCOSA; SALIVA;

EID: 58149385651     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808701206     Document Type: Article

References (68)

1. al-Bayaty HF, Aldred MJ, Walker DM, Newcombe RO, Swift G, Smith PM, et al. (1989). Salivary and scrum antibodies to gliadin in the diagnosis of celiac disease. J Oral Pathol Med 18:578-581.
2. Alaedini A, Green PH (2005). Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 142:289-298.
3. Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, et al. (2007). Antibody responses to deamidaled gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Clin Exp Immunol 150:285-293.
4. Baldas V, Tommasini A, Santon D, Not T, Gerarduzzi T, Clarich G, et al. (2004). Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease. Clin Chem 50:216-219.
5. Bonaroico M, Petri M, Nenna R, Verrienti A, Di Mario U, Tiberti C (2004). Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening. J Pediatr 144:632-636.
6. Brandtzaeg P (2007a). Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann NY Acad Sci 1098:288-311.
7. Brandtzaeg P (2007b). Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25:5467-5484.
8. Brandtzaeg P, Johansen FE (2005). Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 206:32-63.
9. Brousse N, Meijer JW (2005). Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19:401-412.
10. Carroccio A, Campisi G, Iacono G, Iacono OL, Maresi E, Di Prima L, et al. (2007). Oral mucosa of coeliac disease patients produces antiendomysial and antitransglutaminase antibodies: the diagnostic usefulness of an in vitro culture system. Aliment Pharmacol Ther 25:1471-1477.
11. Chiappin S, Antonelli G, Gatti R, De Palo EF (2007). Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 383:30-40.
12. Ciccone E, Truini M, Grossi CE (1998). Lymphoid complement of the human salivary glands: function and pathology. Eur J Morphol 36(Suppl):252-256.
13. Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, et al. (2003). Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52:218-223.
14. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. (2001). Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358:356-361.
15. Dewar DH, Ciclitira PJ (2005). Clinical features and diagnosis of celiac disease. Gastroenterology 128(4 Suppl 1):19S-24S.
16. Dewar DH, Amato M, Ellis HJ, Pollock EL, Gonzalez-Cinca N, Wieser H, et al. (2006). The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease. Eur J Gastroenterol Hepatol 18:483-491.
17. Di Leo M, Weisz G, Ansaldi Balocco N (1999). Serum and salivary antiendomysium antibodies in the screening of coeliac disease. Panminerva Med 41:68-71.
18. Dieterich W, Schuppan D (2007). Is gliadin harmful from the first morsel? Dig Liver Dis 39:917-921.
19. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riechen EO, et al. (1997). Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797-801.
20. Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, et al. (2006). Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 41:408-419.
21. Ellis HJ, Ciclitira PJ (2001). In vivo gluten challenge in celiac disease. Can J Gastroenterol 15:243-247.
22. Pasano A (2003). European and North American populations should be screened for coeliac disease. Gut 52:168-169.
23. Fleckenslcin B, Qiao SW, Larson MR, Jung G, Roepslorff P, Sollid LM (2004). Molecular characterization of covalenl complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 279:17607-17616.
24. Gass J, Bethune MT, Siegel M, Spencer A, Khosla C (2007). Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 133:472-480.
25. Gibney MJ, Brady C (1991). Systemic and salivary antibodies to dietary antigens (gliadin, casein and ovalbumin) in treated and untreated coeliac disease and in Crohn's disease. Eur J Int Med 2:115-119.
26. Green PH, Cellier C (2007). Celiac disease. N Engl J Med 357:1731-1743.
27. Hakeem V, Fifield R, al-Bayaty HF, Aldred MJ, Walker DM, Williams J, et al. (1992). Salivary IgA antigliadin antibody as a marker for coeliac disease. Arch Dis Child 67:724-727.
28. Halblaub JM, Renno J, Kempf A, Bartel J, Schmidt-Gayk H (2004). Comparison of different salivary and fecal antibodies for the diagnosis of celiac disease. Clin Lab 50:551-557.
29. Hansson T, Dannaeus A, Kraaz W, Sjoberg O, Klareskog L (1997). Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospol technique for screening and follow-up. Pedialr Res 41(4 Pt l):554-559.
30. Hill ID, Bhatnagar S, Cameron DJ, De Rosa S, Maki M, Russell GJ, et al. (2002). Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pedialr Gastroenterol Nutr 35(Suppl 2):78-88.
31. Howdle PD (2006). Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease. Eur J Gastroenterol Hepatol 18:703-706.
32. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. (2004). A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367-377.
33. Ivarsson A, Hernell O, Stenlund H, Persson LA (2002). Breast-feeding protects against celiac disease. Am J Clin Nutr 75:914-921.
34. Johansen FE, Braathen R, Munthe E, Schjerven H, Brandtzaeg P (2007). Regulation of the mucosal IgA system. In: Mucosal immune defense: immunoglobulin A. Kaetzel CS, editor. New York: Springer, pp. 111-143.
35. Kagnoff MF (2007). Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 117:41-49.
36. Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, Weir DG (1991). Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci 36:743-751.
37. Lähteenoja H, Toivanen A, Viander M, Mäki M, Irjala K, Raiha 1, et al. (1998). Oral mucosal changes in coeliac patients on a gluten-free diet. Eur J Oral Sci 106:899-906.
38. Lähteenoja H, Toivanen A, Raiha I, Syrjänen S, Viander M (1999). Salivary antigliadin and antiendomysium antibodies in coeliac disease. Scand J Immunol 50:528-535.
39. Lähteenoja H, Toivanen A, Viander M, Raiha I, Ranlala I, Syrjänen S, et al. (2000a). Increase in T-cell subsets of oral mucosa: a late immune response in patients with treated coeliac disease? Scand J Immunol 52:602-608.
40. Lähteenoja H, Mäki M, Viander M, Raiha I, Vilja P, Rantala I, et al. (2000b). Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol 95:2880-2887.
41. Lähtccnoja H, Mäki M, Viander M, Toivanen A, Syrjäncn S (2000c), Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin Exp Immunol 120:38-45.
42. Loft DE, Marsh MN, Crowe PT (1990). Rectal gluten challenge and diagnosis of coeliac disease. Lancet 335:1293-1295.
43. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. (2003). Association between innate response to gliadin and activation of pathogenic T cells in coeliae disease. Lancet 362:30-37.
44. Mearin ML, Ivarsson A, Dickey W (2005). Coeliac disease: is it lime for mass screening? Best Pract Res Clin Gastroenterol 19:441-452.
45. Meresse B, Chen Z, Olszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. (2004). Coordinated induction by IL 15 of a TCR-independent NKG2D signaling pathway converts CTL into iymphokine-activated killer cells in celiac disease. Immunity 21:357-366.
46. Michishige F, Kanno K, Yoshinaga S, Hinode D, Takehisa Y, Yasuoka S (2006). Effect of saliva collection method on the concentration of protein components in saliva. J Med Invest 53:140-146.
47. Mitea C, Havenaar R, Drijfhout JW, Edens L, Dekking L, Koning F (2008), Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 57:25-32.
48. Nair PN, Schroeder HE (1986). Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology 57:171-180.
49. Nistico L, Fagnani C, Coto I, Percopo S, Cotiehini R, Limongelli MG, et al. (2006). Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55:803-808.
50. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, et al. (2005), Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. J Am Med Assoc 293:2343-2351.
51. Nurkka A, Obiero J, Kayhty H, Scott JA (2003). Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva. Clin Diagn Lab Immunol 10:357-361.
52. O'Mahony S, Arranz E, Barton JR, Ferguson A (1991). Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut 32:29-35.
53. Ocmant A, Mascart F (2007). Effective detection of celiac disease using salivary anti-transglutaminase. Am J Med 120:el 5.
54. Patinen P, Bjorksten F, Malmsirom M, Savilahti E, Reunala T (1995). Salivary and serum IgA antigliadin antibodies in dermatitis herpetiformis. Eur J Oral Sci 103:280-284.
55. Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003). Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163:1566-1572.
56. Picarelli A, Di Tola M, Sabbatella L, Anania MC, Calabro A, Renzi D, et al. (2006). Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 41:186-190.
57. Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. (2005). The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128(4 Suppl 1):38S-46S.
58. Rostom A, Murray JA, Kagnoff MF (2006). American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131:1981-2002.
59. Rujner J, Socha J, Barra E, Gregorek H, Madalinski K, Wozniewicz B, et al. (1996). Serum and salivary antigliadin antibodies and serum IgA anti-endomysium antibodies as a screening test for coeliac disease. Acta Paediatr 85:814-817.
60. Schuppan D (2000). Current concepts of celiac disease pathogenesis. Gastroenterology 119:234-242.
61. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, et al. (2002). Structural basis for gluten intolerance in celiac sprue. Science 297:2275-2279.
62. Shan L, Qiao SW, Arentz-Hansen H, Molberg O, Gray GM, Sollid EM, et al. (2005). Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res 4:1732-1741.
63. Stene EC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol R.T, Emery L, et al. (2006). Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood; a longitudinal study. Am J Gastroenterol 101:2333-2340.
64. van Heel DA, West J (2006). Recent advances in coeliac disease. Gut 55:1037-1046.
65. Vetrano S, Zampaletta U, Anania MC, Di Tola M, Sabbatella L, Passarelli F, et al. (2007). Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease. Dig Liver Dis 39:911-916.
66. Volta U, Granito A, Fiorini E, Parisi C, Piscaglia M, Pappas G, et al. (2008). Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 53:1582-1588.
67. Wieser H (2007). Chemistry of gluten proteins. Food Microbiol 24:115-119. Wolters VM, Wijmenga C (2008). Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 103:190-195.
68. Zanoni G, Navono R, Lunardi C, Tridente G, Bason C, Sivori S, et al. (2006). In celiac disease, a subset of autoantibodies against transglutaminase binds Toll-like receptor 4 and induces activation of monocytes. PLoS Med 3:e358.